We contribute to medical care through innovative drug discovery using the technologies of cell-free membrane protein preparation and non-canonical amino acid incorporation into target proteins.
Company | LiberoThera Co., Ltd. | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Registered Office | Nihonbashi Life Science Building 7, 8F 1-9-10 Nihonbashi-horidomecho, Chuo-ku, Tokyo 103-0012, Japan |
||||||||||||||
TIP Laboratory | Tokyo Medical and Dental University/ Bldg.8 TIP LAB #516 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, JAPAN |
||||||||||||||
Establishment | April 3, 2018 | ||||||||||||||
CEO | Toru Kanke, Ph.D. | ||||||||||||||
Business | Drug discovery targeting on membrane proteins and drug discovery services | ||||||||||||||
Capital | 100,000,000 yen(As of April 1, 2022) | ||||||||||||||
Number of Officers & Employees | 13(As of April 1, 2022) | ||||||||||||||
Main Bank | MUFG Bank, Ltd., Mizuho Bank, Ltd. | ||||||||||||||
Corporate History |
|